A recombinant human interleukin-1 receptor antagonist (IL-IRa) that binds avidly to type 1 IL-1 receptors but does not stimulate any intracellular responses, used to treat rheumatoid arthritis and other inflammatory diseases.
As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
